MHC-II-Independent CD4+ T cells induce colitis in immunodeficient RAG-/- hosts

被引:33
作者
Trobonjaca, Z
Leithäuser, F
Möller, P
Bluethmann, H
Koezuka, Y
MacDonald, HR
Reimann, J
机构
[1] Univ Ulm, Dept Immunol & Med Microbiol, D-89081 Ulm, Germany
[2] Univ Ulm, Dept Pathol, D-89081 Ulm, Germany
[3] Hoffmann La Roche Ag, Roche Genet, Basel, Switzerland
[4] Kirin Brewery, Pharmaceut Res Lab, Gunma, Japan
[5] Ludwig Inst Canc Res, CH-1066 Epalinges, Switzerland
关键词
D O I
10.4049/jimmunol.166.6.3804
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
CD4(+) alpha betaT cells from either normal C57BL/6 (B6) or MHC-II-deficient (A alpha (-/-) or A beta (-/-)) B6 donor mice engrafted into congenic immunodeficient RAG1(-/-) B6 hosts induced an aggressive inflammatory bowel disease (IBD), Furthermore, CD4+ T cells from CDld(-/-) knockout (KO) B6 donor mice but not those from MHC-I-/- (homozygous transgenic mice deficient for beta (2)-micro-globulin) KO B6 mice induced a colitis in RAG(-/-) hosts, Abundant numbers of in vivo activated (CD69(high)CD44(high)CD28(high)) NK1(+) and NK1(-) CD4(+) T cells were isolated from the inflamed colonic lamina propria (cLP) of transplanted mice with LED that produced large amounts of TNF-alpha and IFN-gamma but low amounts of IL-4 and IL-10, IBD-associated cLP Th1 CD4(+) T cell populations were polyclonal and MHC-II-restricted when derived from normal B6 donor mice, but oligoclonal and apparently MHC-I-restricted when derived from MHC-LI-deficient (A alpha (-/-) or A beta (-/-)) B6 donor mice. cLP CD4(+) T cell populations from homozygous transgenic mice deficient for beta (2)-microglobulin KO B6 donor mice engrafted into RAG(-/-) hosts were Th2 and MHC-II restricted, These data indicate that MHC-II-dependent as well as MHC-II-independent CD4(+) T cells can induce a severe and lethal PBD in congenic, immunodeficient hosts, but that the former need the latter to express its IBD-inducing potential.
引用
收藏
页码:3804 / 3812
页数:9
相关论文
共 61 条
[1]   Regulatory CD4 T cells control the size of the peripheral activated/memory CD4 T cell compartment [J].
Annacker, O ;
Burlen-Defranoux, O ;
Pimenta-Araujo, R ;
Cumano, A ;
Bandeira, A .
JOURNAL OF IMMUNOLOGY, 2000, 164 (07) :3573-3580
[2]  
Aranda R, 1997, J IMMUNOL, V158, P3464
[3]   CD8+ T cells rapidly acquire NK1.1 and NK cell-associated molecules upon stimulation in vitro and in vivo [J].
Assarsson, E ;
Kambayashi, T ;
Sandberg, JK ;
Hong, S ;
Taniguchi, M ;
Van Kaer, L ;
Ljunggren, HG ;
Chambers, BJ .
JOURNAL OF IMMUNOLOGY, 2000, 165 (07) :3673-3679
[4]   Mouse CD1-specific NK1 T cells: Development, specificity, and function [J].
Bendelac, A ;
Rivera, MN ;
Park, SH ;
Roark, JH .
ANNUAL REVIEW OF IMMUNOLOGY, 1997, 15 :535-562
[5]   In vivo identification of glycolipid antigen-specific T cells using fluorescent CD1d tetramers [J].
Benlagha, K ;
Weiss, A ;
Beavis, A ;
Teyton, L ;
Bendelac, A .
JOURNAL OF EXPERIMENTAL MEDICINE, 2000, 191 (11) :1895-1903
[6]   Cytotoxic reactivity of gut lamina propria CD4(+) alpha beta T cells in SCID mice, with colitis [J].
Bonhagen, K ;
Thoma, S ;
Bland, P ;
Bregenholt, S ;
Rudolphi, A ;
Claesson, MH ;
Reimann, J .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1996, 26 (12) :3074-3083
[7]  
Bonhagen K, 1998, CLIN EXP IMMUNOL, V112, P443
[8]  
BRIMNES J, IN PRESS EUR J IMMUN
[9]   CD1d-mediated recognition of an α-galactosylceramide by natural killer T cells is highly conserved through mammalian evolution [J].
Brossay, L ;
Chioda, M ;
Burdin, N ;
Koezuka, Y ;
Casorati, G ;
Dellabona, P ;
Kronenberg, M .
JOURNAL OF EXPERIMENTAL MEDICINE, 1998, 188 (08) :1521-1528
[10]  
Brossay L, 1998, J IMMUNOL, V161, P5124